Fresenius Medical Care (FMS) Tops Q2 EPS by 19c

Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of EUR0.81, EUR0.19 better than the analyst estimate of EUR0.62. Revenue for the quarter came in at EUR4.86 billion versus the consensus estimate of EUR5.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Bessent on Iran: maximum economic pressure means likely not a kinetic restart
• Bessent says may raise bond buyback beyond $4 billion
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance